Behrad Derakhshan, Chief Business Officer at Edgewise Therapeutics, Inc. (EWTX), sold 5,100 shares at $43.79 ($223K) on 2026-08-12, disclosed to the SEC on 2026-08-14.
Open-market sale of $223k EWTX by Chief Business Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $43.70 | 2,475 | $108K | 48.4% |
| 2 | $43.79 | 2,171 | $95K | 42.6% |
| 3 | $44.44 | 150 | $7K | 3.0% |
| 4 | $44.50 | 304 | $14K | 6.1% |
| Total | $43.81 avg | 5,100 | $223K | 100% |
| Filing → |
| EWTX | SELL | 2025-02-07 | $300K | — | Filing → |
| EWTX | SELL | 2024-09-24 | $2.4M | — | Filing → |
| EWTX | SELL | 2024-05-03 | $32K | — | Filing → |